Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 11 min ago
PreprintCC BYbioRxiv

Failed allogeneic corneal lenticules show fibrosis and identity loss without dominant T cell rejection

  1. 1Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Abstract

Failed allogeneic corneal stromal lenticules develop progressive opacity, but the state of the implanted tissue is unknown. Here we show that six explants from three patients occupy a fibrotic integration-failure state with scar-matrix production and loss of corneal identity without a dominant T cell rejection program. Scar-matrix, transparency and corneal-identity programs separated every patient from eight unimplanted donor controls, the last defined by independent human single-cell references. Calibrated immune programs and repertoire reconstruction distinguished the explants from canonical adaptive rejection. Exchange reduced interface reflectivity initially, followed by recurrent opacity in two patients and corneal steepening with declining uncorrected acuity in the third. In non-scarring rabbit repair, identity moved toward the uninjured state as backscatter returned toward normal despite increasing similarity to the explant-derived expression signature. Within one culture experiment, marked scar suppression accompanied opposite identity responses. Tacrolimus and rapamycin likewise suppressed canonical rejection while moving identity in opposite directions. Resveratrol combined reduced scar-associated programs and increased identity with improved graft appearance in the source study. These findings establish classic-rejection activity and tissue integration as separable axes and direct treatment of failed lenticules from escalating immunosuppression toward control of stromal remodeling and preservation of corneal identity.

Related

  1. Stuck in traffic: a bispecific antibody-mediated immune re-engagement after allogeneic stem cell transplantation
    Stephanie Boisclair, Monica Wallin, Sally Ko +1
    HaematologicaPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  2. The Tell-Tale Heart ― Persistent Immune Activation in Histologically Rejection-Free Heart Transplant Recipients ―
    Toshiyuki Ko, Hiroyuki Morita
    Circulation JournalPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaJ-STAGE
  3. First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access
    Wojciech Wystrychowski, Todd Mcallister, Krzysztof Zagalski +3
    Journal of Vascular SurgeryPeer-reviewedLicence not statedFull text203 citedSurgery & anaesthesiaHAL
  4. Post Heart Transplantation Immunosuppression and Rejection: What the General Cardiologist Needs to Know
    Rashmi Jain, Michelle M. Kittleson
    Heart (British Cardiac Society)Peer-reviewedLicence not statedFull textSurgery & anaesthesiaPMC
  5. The role of allogeneic hematopoietic stem cell transplantation in adults with mature T‐cell lymphomas
    Laura Diana Stocker, Lisa Thielecke, Constantin Schmitz +3
    The Cochrane Database of Systematic ReviewsPeer-reviewedPublisher termsFull textGeneral medicinePMC
BibTeX
@misc{jiang2026failed,
  title = {{Failed allogeneic corneal lenticules show fibrosis and identity loss without dominant T cell rejection}},
  author = {H. Jiang and Y. Di and C. Li and Y. Jiang and Y. Li and Y. Zhou},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.04.764222},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.04.764222v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Failed allogeneic corneal lenticules show fibrosis and identity loss without dominant T cell rejection
AU  - H. Jiang
AU  - Y. Di
AU  - C. Li
AU  - Y. Jiang
AU  - Y. Li
AU  - Y. Zhou
PY  - 2026
DA  - 2026/11/04
PB  - bioRxiv
DO  - 10.64898/2026.11.04.764222
UR  - https://www.biorxiv.org/content/10.64898/2026.11.04.764222v1
AB  - Failed allogeneic corneal stromal lenticules develop progressive opacity, but the state of the implanted tissue is unknown. Here we show that six explants from three patients occupy a fibrotic integration-failure state with scar-matrix production and loss of corneal identity without a dominant T cell rejection program. Scar-matrix, transparency and corneal-identity programs separated every patient from eight unimplanted donor controls, the last defined by independent human single-cell references. Calibrated immune programs and repertoire reconstruction distinguished the explants from canonical adaptive rejection. Exchange reduced interface reflectivity initially, followed by recurrent opacity in two patients and corneal steepening with declining uncorrected acuity in the third. In non-scarring rabbit repair, identity moved toward the uninjured state as backscatter returned toward normal despite increasing similarity to the explant-derived expression signature. Within one culture experiment, marked scar suppression accompanied opposite identity responses. Tacrolimus and rapamycin likewise suppressed canonical rejection while moving identity in opposite directions. Resveratrol combined reduced scar-associated programs and increased identity with improved graft appearance in the source study. These findings establish classic-rejection activity and tissue integration as separable axes and direct treatment of failed lenticules from escalating immunosuppression toward control of stromal remodeling and preservation of corneal identity.
ER  -